Literature DB >> 11170080

Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG.

H Yoshida1, M Horie, H Otani, T Kawashima, Y Onishi, S Sasayama.   

Abstract

Long QT syndrome is a congenital disorder that presents with a defective cardiac ion channel and is either associated with prolonged action potential or, more commonly, known as an acquired form in which "torsades de pointes" type arrhythmias specifically occur after secondary causes. We report a case of a novel HERG mutation (A490T) that caused a bradycardia-associated form of long QT syndrome. A 27-year-old woman exhibited recurrent syncope due to torsades de pointes associated with a disturbance of the cardiac conduction system. By using polymerase chain reaction and single strand conformational polymorphism analyses, we identified a heterozygous single nucleotide substitution of HERG (G to A at nt 1468). This mutational change was not present in 140 Japanese control individuals. Electrophysiological assays for the A490T mutant HERG channel were conducted in the heterologous expression system with COS7 cells. The mutant channel was found to reconstitute functional channel currents, suggesting the homomeric mutant channel was functional. The mutation did not change the properties of the activation gate and inward rectification, however the current density of this mutant channel was small compared with that of wild type HERG. Taken together, this mutant may cause subtle changes in HERG channel functions (I(Kr)) in vivo. In this case, genetic background and unexpected bradycardia may have contributed to the development of long QT syndrome. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170080     DOI: 10.1002/1096-8628(20010201)98:4<348::aid-ajmg1109>3.0.co;2-a

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates.

Authors:  Rajesh N Subbiah; Michael H Gollob; Lorne J Gula; Robert W Davies; Peter Leong-Sit; Allan C Skanes; Raymond Yee; George J Klein; Andrew D Krahn
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

2.  Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia.

Authors:  James P Lees-Miller; Jiqing Guo; Julie R Somers; Dan E Roach; Robert S Sheldon; Derrick E Rancourt; Henry J Duff
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

3.  In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs).

Authors:  C Sudandiradoss; Rao Sethumadhavan
Journal:  Genomic Med       Date:  2009-02-12

Review 4.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.

Authors:  Xianqin Zhang; Shenghan Chen; Li Zhang; Mugen Liu; Sharon Redfearn; Randall M Bryant; Carlos Oberti; G Michael Vincent; Qing K Wang
Journal:  BMC Med Genet       Date:  2008-09-23       Impact factor: 2.103

6.  Torsade de Pointes Triggered by Early Ventricular Escape Beats in a Patient with Complete Atrioventricular Block.

Authors:  Erkan Yildirim; Baris Bugan; Suat Gormel; Uygar Cagdas Yuksel; Murat Celik; Yalcin Gokoglan; Serdar Firtina; Sinan Iscen; Emre Yalcinkaya; Ugur Kucuk; Hasan Kutsi Kabul
Journal:  Case Rep Cardiol       Date:  2016-04-06

7.  Optogenetic sensors in the zebrafish heart: a novel in vivo electrophysiological tool to study cardiac arrhythmogenesis.

Authors:  Chantal J M van Opbergen; Charlotte D Koopman; Bart J M Kok; Thomas Knöpfel; Sabine L Renninger; Michael B Orger; Marc A Vos; Toon A B van Veen; Jeroen Bakkers; Teun P de Boer
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.